A 35-year-old woman from rural Maharashtra presents to the gynecology clinic for routine screening. She is married for 12 years, has 2 children, and reports no abnormal vaginal discharge or bleeding. On examination, the cervix appears normal. Pap smear is performed and reports "ASCUS (Atypical Squamous Cells of Undetermined Significance)." HPV testing is negative. What is the most appropriate next step in management?

Explanation

## Management of ASCUS with Negative HPV Testing **Key Point:** ASCUS (Atypical Squamous Cells of Undetermined Significance) is a low-grade cytologic abnormality. When HPV testing is negative, the risk of underlying cervical intraepithelial neoplasia (CIN) or malignancy is very low (<5%). **High-Yield:** The 2012 ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines recommend: - **ASCUS + HPV positive** → Colposcopy - **ASCUS + HPV negative** → Routine screening (repeat cytology in 12 months or HPV testing in 3 years) ### Rationale for Repeat Pap Smear in 12 Months When HPV is negative in the setting of ASCUS: 1. The cytologic abnormality is likely a benign mimicker or processing artifact 2. The absence of high-risk HPV types (16, 18, 31, 33, etc.) indicates minimal oncogenic risk 3. Return to routine screening with repeat Pap in 12 months is safe and cost-effective 4. This approach avoids unnecessary colposcopy and reduces healthcare burden **Clinical Pearl:** HPV negativity is the most reassuring finding in ASCUS cases. A negative HPV test essentially "clears" the patient from immediate intervention. **Mnemonic:** **ASCUS-HPV Rule** - **Positive HPV** → Colposcopy (risk of CIN ~40%) - **Negative HPV** → Routine screening (risk of CIN <5%) ### Why Other Options Are Not Preferred | Option | Why Not Ideal | |--------|---------------| | Immediate colposcopy | Unnecessary when HPV is negative; increases cost and patient anxiety | | HPV vaccination at age 35 | Not indicated for screening purposes; vaccination is preventive, not therapeutic | | Excisional biopsy | Invasive and inappropriate without colposcopic findings | [cite:ASCCP 2012 Cervical Cancer Screening Guidelines]